LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set— 510(k) K162969
Substantially EquivalentDiaSorin, Inc.
FDA 510(k) clearance K162969 for LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set, Substantially Equivalent on 2017-01-06. Applicant: DiaSorin, Inc.. Device class: 2.
Clearance details
- Applicant
- DiaSorin, Inc.
- Product code
- Code LFZ
- Device class
- Class 2
- Regulation
- 21 CFR 866.3175
- Advisory panel
- Microbiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Stillwater, MN, US
Recent devices under product code LFZ
view allMore clearances from DiaSorin, Inc.
view all- K260770 — LIAISON Murex HBsAg Qual; LIAISON XL; LIAISON diluteX
- DEN250032 — LIAISON® XL MUREX Anti-HDV (318260); LIAISON® XL MUREX Control Anti-HDV (318261)
- K231214 — LIAISON VZV IgG HT, LIAISON Control VZV IgG HT
- K223403 — LIAISON Anti-HAV; LIAISON XS
- K213858 — LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus
Data sourced from openFDA. This site is unofficial and independent of the FDA.